| Nelson H Lim, MD | |
|
2680 S Val Vista Dr, Suite 116, Gilbert, AZ 85295-2152 | |
| (480) 507-5678 | |
| (480) 507-5677 |
| Full Name | Nelson H Lim |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 22 Years |
| Location | 2680 S Val Vista Dr, Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366463168 | NPI | - | NPPES |
| 00A879870 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 42036 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Desert Medical Center | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Centers For Digestive Health Llc | 5193083087 | 22 |
| Banner Physician Specialists Arizona Llc | 6204002272 | 258 |
News Archive
BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.
Scientists led by Dr. Salvador Aznar-Benitah, head of the Stem Cells and Cancer laboratory at IRB Barcelona, have described the alterations that occur during mammary gland formation when heterochromatin (the part of DNA that does not actively produce proteins) is poorly regulated.
A group of researchers at the University of São Paulo in Brazil used a DNA editing tool called CRISPR/Cas9 to manipulate on of the genes associated to the autoaggressive T lymphocytes responsible for inducing autoimmune diseases such as autoimmune polyglandular syndrome type 1 and type 1 diabetes.
Once again, the end of the NHS financial year is fast approaching with GP surgeries preparing for their busiest time of year in the lead up to 31st March 2017.
The Oklahoma Board of Medical Licensure and Supervision has launched two new online services providing simple government transactions for the medical community.
› Verified 1 days ago
| Entity Name | Banner Physician Specialists Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316228802 PECOS PAC ID: 6204002272 Enrollment ID: O20111222000509 |
News Archive
BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.
Scientists led by Dr. Salvador Aznar-Benitah, head of the Stem Cells and Cancer laboratory at IRB Barcelona, have described the alterations that occur during mammary gland formation when heterochromatin (the part of DNA that does not actively produce proteins) is poorly regulated.
A group of researchers at the University of São Paulo in Brazil used a DNA editing tool called CRISPR/Cas9 to manipulate on of the genes associated to the autoaggressive T lymphocytes responsible for inducing autoimmune diseases such as autoimmune polyglandular syndrome type 1 and type 1 diabetes.
Once again, the end of the NHS financial year is fast approaching with GP surgeries preparing for their busiest time of year in the lead up to 31st March 2017.
The Oklahoma Board of Medical Licensure and Supervision has launched two new online services providing simple government transactions for the medical community.
› Verified 1 days ago
| Entity Name | Arizona Centers For Digestive Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568975316 PECOS PAC ID: 5193083087 Enrollment ID: O20171226000651 |
News Archive
BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.
Scientists led by Dr. Salvador Aznar-Benitah, head of the Stem Cells and Cancer laboratory at IRB Barcelona, have described the alterations that occur during mammary gland formation when heterochromatin (the part of DNA that does not actively produce proteins) is poorly regulated.
A group of researchers at the University of São Paulo in Brazil used a DNA editing tool called CRISPR/Cas9 to manipulate on of the genes associated to the autoaggressive T lymphocytes responsible for inducing autoimmune diseases such as autoimmune polyglandular syndrome type 1 and type 1 diabetes.
Once again, the end of the NHS financial year is fast approaching with GP surgeries preparing for their busiest time of year in the lead up to 31st March 2017.
The Oklahoma Board of Medical Licensure and Supervision has launched two new online services providing simple government transactions for the medical community.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nelson H Lim, MD 3707 N 7th St Ste 200, Phoenix, AZ 85014-5095 Ph: (480) 507-5678 | Nelson H Lim, MD 2680 S Val Vista Dr, Suite 116, Gilbert, AZ 85295-2152 Ph: (480) 507-5678 |
News Archive
BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.
Scientists led by Dr. Salvador Aznar-Benitah, head of the Stem Cells and Cancer laboratory at IRB Barcelona, have described the alterations that occur during mammary gland formation when heterochromatin (the part of DNA that does not actively produce proteins) is poorly regulated.
A group of researchers at the University of São Paulo in Brazil used a DNA editing tool called CRISPR/Cas9 to manipulate on of the genes associated to the autoaggressive T lymphocytes responsible for inducing autoimmune diseases such as autoimmune polyglandular syndrome type 1 and type 1 diabetes.
Once again, the end of the NHS financial year is fast approaching with GP surgeries preparing for their busiest time of year in the lead up to 31st March 2017.
The Oklahoma Board of Medical Licensure and Supervision has launched two new online services providing simple government transactions for the medical community.
› Verified 1 days ago
Sandhyaben P Patel, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-543-2134 Fax: 480-512-6089 | |
Dr. Shivakumar Vignesh, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr., Suite 400, Gilbert, AZ 85234 Phone: 480-256-3332 Fax: 813-449-8028 | |
Dr. Noreen Catherine Ruane, D.O. Gastroenterology Medicare: Medicare Enrolled Practice Location: 3555 S Val Vista Dr, Gilbert, AZ 85297 Phone: 602-933-0777 Fax: 602-933-0755 | |
Dr. Ala Eddin Samir Sagar, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2940 E Banner Gateway Drive, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Theresa Ong Liu Dumlao, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-4683 | |
Dr. Zachary Phillip Yeung, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-245-6444 Fax: 480-256-4623 | |
Richard D Sue, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 |